Polynucleotide skin boosters and PDLLA-HA collagen biostimulators are both injectable treatments used in aesthetic medicine and are often grouped together under the skin booster label in patient-facing content. The comparison between them comes up often, but the two are not the same. They use different active ingredients, work through different biological mechanisms, and address different aspects of skin condition. Understanding what each does helps patients and doctors decide which is appropriate, or whether both have a role in a wider treatment plan.
What is a PDRN Skinbooster?
PDRN Skinboosters is a type of polynucleotide-based skin treatment derived from salmon DNA, and is administered through a series of micro-injections into the dermal layer. Its active ingredient, polydeoxyribonucleotide (PDRN), is thought to support skin repair processes at the cellular level, which is why this skin booster is often categorised as regenerative rather than volumising.
Because the focus is on skin quality rather than volume, polynucleotide skin boosters work differently from injectables that fill or lift. They may contribute to improvements in skin texture, elasticity, and hydration over a course of sessions, with the response developing gradually as the skin reacts to the treatment. A typical protocol involves several sessions spaced over a few weeks.
What is a PDLLA-HA Skinbooster?
PDLLA-HA Skinbooster belongs to a different injectable category. Rather than acting directly on skin repair processes, this class of treatment works by stimulating the skin’s own collagen response over time through a combination of poly-D,L-lactic acid (PDLLA) and hyaluronic acid (HA).
The HA component provides a degree of hydration after injection, while the PDLLA microparticles are gradually metabolised. During this process, they may stimulate fibroblast activity and contribute to new collagen formation in the treated area. This is why PDLLA-HA biostimulators are often discussed in relation to supporting firmness and the gradual appearance of volume over months rather than days. As with other biostimulators, the response builds across a course of sessions.
Key Differences at a Glance
With the two mechanisms established, the practical differences become clearer. PDLLA-HA Skinbooster and PDRN Skinbooster differ across several clinical dimensions:
- Active ingredient: Polynucleotide (PDRN) for the regenerative class; PDLLA combined with hyaluronic acid for the biostimulator class.
- Primary mechanism: Polynucleotide skin boosters are thought to support cellular skin repair. PDLLA-HA biostimulators stimulate collagen formation through a biostimulatory response.
- Depth of injection: Polynucleotide treatments are typically administered into the dermal layer. PDLLA-HA biostimulators are generally injected into the deeper dermal or subdermal layer, depending on the area treated.
- Typical use cases: Polynucleotide skin boosters are more often used in relation to texture, elasticity, and overall skin quality. PDLLA-HA biostimulators are more commonly used to support collagen activity, firmness, and the appearance of volume.
These distinctions matter because the appropriate choice depends on what the patient’s skin requires, not on which treatment is more familiar.
Can They Be Used Together?
Given how differently the two work, it is reasonable to ask whether they can be combined. In some treatment plans, biostimulators and regenerative injectables may be used together, with one addressing skin quality and the other supporting collagen activity over time.
Whether this is appropriate and how the two should be sequenced, if both are used, depends on the patient’s skin condition, the areas being treated, and the wider plan agreed during consultation. Combination approaches are determined clinically rather than offered as standard protocols.
How to Know Which is More Suitable for You
Suitability for either treatment depends on factors that can only be evaluated during consultation: skin condition, age, the specific concerns the patient wants to address, medical history, and the broader treatment plan recommended by the doctor.
A patient whose primary concerns are texture, fine lines, and overall skin quality may be guided toward a polynucleotide option. A patient looking to support firmness and gradual collagen rebuilding may be guided toward a PDLLA-HA biostimulator. In some cases, neither is appropriate as a first-line treatment, and the doctor may recommend a different approach altogether.
Results vary between individuals, and not every patient is a suitable candidate for these treatments. Possible side effects should be discussed with a qualified doctor before proceeding.
Speak With Our Doctors
Patients considering skin booster or biostimulator options can reach out to our aesthetic clinic in Singapore, where treatment recommendations are made based on individual assessment rather than fixed packages. More information about the PDLLA-HA Skinbooster offered at the clinic is available to patients specifically interested in the treatment.